Patent · US Active

cKIT antibody drug conjugates

US9789203B2 · kind B2 · utility

3Cited by

36References

31Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Tinya Abrams · Richmond, US
Steven Bruce Cohen · San Diego, US
Christie P. Fanton · Oakland, US
Catrin Finner · Planegg, DE
Thomas Huber · Basel, CH
Kathy Miller · San Francisco, US
Siew Ho Schleyer · Emeryville, US
Kathrin Ulrike Tissot-Daguette · Schwanau, DE

Key dates

Filing date	Mar 12, 2014
Grant date	Oct 17, 2017
Priority date	—
Expiry date	Mar 12, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.